Skip to content

Regenxbio RGNX Interest Income

Interest Income at other companies

BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
$22.56M+18.7%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$6M-14.3%
4D Molecular Therapeutics logo
4D Molecular TherapeuticsFDMT
$4.86M-12.9%
Solid Biosciences Inc. logo
Solid Biosciences Inc.SLDB
$2.06M-10.3%
Immix Biopharma, Inc. logo
Immix Biopharma, Inc.IMMX
$717.17K+377%
Biogen logo
BiogenBIIB

Other financials

Income statement

See full
Revenue$6.4M-92.8%
Gross profit$14.9M+35.7%
Operating income-$83.4M-787%
Net income-$90.1M-1,580%
EPS (diluted)-$1.72-1,533%

Balance sheet

See full
Cash & equivalents$15.2M-88.3%
Total debt$71.1M-11.0%
Total equity$21.1M-92.3%
Total assets$341.9M-30.4%

Cash flow

See full
Operating cash flow-$76.2M-327%
CapEx$1.2M+20.6%
Free cash flow-$77.4M-337%

Valuation

See full
Market cap$529.38M+24.6%
Enterprise value$585.22M+56.3%
P/S+3.3×

Profitability

See full
Gross margin59.7%+1.0pp
Operating margin-292.3%-613pp
Net margin-330.2%-588pp
FCF margin-269.2%-364pp

Returns & leverage

See full
Return on equity-196.4%-288pp
Debt / equity3.4×+3.1×
Current ratio2.6×-0.3×

Where this comes from

Reported directly by Regenxbio in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeNet.

The official record: Regenxbio’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Regenxbio's interest income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Regenxbio's interest income?
Regenxbio (RGNX) reported interest income of $2M in Q1 2026.
How has Regenxbio's interest income changed year-over-year?
Regenxbio's interest income decreased by 19.9% year-over-year, from $2.5M to $2M.
What is the long-term trend for Regenxbio's interest income?
Over 4 years (2021 to 2025), Regenxbio's interest income has grown at a 15.7% compound annual growth rate (CAGR), from $6.83M to $12.25M.
What does interest income mean?
Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.